Back to mobile site

More on AKBA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.8 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Akebia Therapeutics (NQ:AKBA)
Delayed: 1.10 +0.01 (0.92%)
Prev. Close $1.09  
Open$1.09 
52 Wk High$13.20 
52 Wk Low$7.00 
Day High$1.14 
Day Low$1.09 
P/E N/A  
EPS$0.00 
Volume2,437,812 


Jun 22, 2026 04:25 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: Wolf Myles
Jun 22, 2026 04:24 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: Smith Cynthia
Jun 22, 2026 04:22 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: ROGERS MICHAEL W
Jun 22, 2026 04:20 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: FRIESON RON
Jun 22, 2026 04:17 PM Form 8-K Akebia Therapeutics, For: Jun 17
Jun 22, 2026 04:11 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: ZUMWALT LEANNE M
Jun 22, 2026 04:09 PM Form 4 Akebia Therapeutics, For: Jun 17 Filed by: ADAMS ADRIAN
Jun 10, 2026 08:02 AM Akebia Therapeutics strengthens Vafseo patent portfolio with new grant
Jun 10, 2026 08:00 AM Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
Jun 1, 2026 04:05 PM Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View All Articles

Entities mentioned with AKBA

View All Entities